Literature DB >> 20382726

Therapeutic serum concentrations of daptomycin after intraperitoneal administration in a patient with peritoneal dialysis-associated peritonitis.

Svenja K Bahte, Anna Bertram, Olaf Burkhardt, Jens Martens-Lobenhoffer, Vega Goedecke, Stefanie M Bode-Böger, Marcus Hiss, Jan T Kielstein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20382726     DOI： 10.1093/jac/dkq118

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  10 in total

1.  Effect of glucose concentration on the stability of daptomycin in peritoneal solutions.

Authors:  Maria Asunción Parra; Miguel Angel Campanero; Belen Sádaba; Angel Irigoyen; Laura García-López; Maria Jose Fernandez-Reyes; Jose Ramon Azanza
Journal:  Perit Dial Int       Date:  2013 Jul-Aug       Impact factor: 1.756

2.  Pharmacokinetics and pharmacodynamics of intravenous daptomycin during continuous ambulatory peritoneal dialysis.

Authors:  Katie E Cardone; Thomas P Lodise; Nimish Patel; Christopher D Hoy; Shari Meola; Harold J Manley; George L Drusano; Darren W Grabe
Journal:  Clin J Am Soc Nephrol       Date:  2011-03-10       Impact factor: 8.237

3.  The influence of different peritoneal dialysis fluids on the in vitro activity of ampicillin, daptomycin, and linezolid against Enterococcus faecalis.

Authors:  M Kussmann; L Schuster; M Zeitlinger; P Pichler; G Reznicek; M Wiesholzer; H Burgmann; W Poeppl
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-09-04       Impact factor: 3.267

Review 4.  Treatment of enterococcal peritonitis with intraperitoneal daptomycin in a vancomycin-allergic patient and a review of the literature.

Authors:  James F Gilmore; Miae Kim; Mary T LaSalvia; Monica V Golik Mahoney
Journal:  Perit Dial Int       Date:  2013 Jul-Aug       Impact factor: 1.756

5.  Successful Treatment of a Pacemaker Infection with Intraperitoneal Daptomycin.

Authors:  Anne B Taegtmeyer; Nina Kononowa; Dominique Fasel; Manuel Haschke; Felix Burkhalter
Journal:  Perit Dial Int       Date:  2016 Jan-Feb       Impact factor: 1.756

Review 6.  Clinical Pharmacokinetics of Daptomycin.

Authors:  Nicolas Gregoire; Alexia Chauzy; Julien Buyck; Blandine Rammaert; William Couet; Sandrine Marchand
Journal:  Clin Pharmacokinet       Date:  2020-12-14       Impact factor: 6.447

7.  Newer antibiotics for the treatment of peritoneal dialysis-related peritonitis.

Authors:  Terry King-Wing Ma; Chi Bon Leung; Kai Ming Chow; Bonnie Ching-Ha Kwan; Philip Kam-Tao Li; Cheuk Chun Szeto
Journal:  Clin Kidney J       Date:  2016-07-04

Review 8.  Peritoneal dialysis-related peritonitis: challenges and solutions.

Authors:  William L Salzer
Journal:  Int J Nephrol Renovasc Dis       Date:  2018-06-11

9.  Spontaneous Bacterial Peritonitis Due to Methicillin-Resistant Staphylococcus Aureus in a Patient with Cirrhosis: The Potential Role for Daptomycin and Review of the Literature.

Authors:  Marco Falcone; Alessandro Russo; Giovanni Pacini; Manuela Merli; Mario Venditti
Journal:  Infect Dis Rep       Date:  2015-09-29

Review 10.  ISPD Peritonitis Recommendations: 2016 Update on Prevention and Treatment.

Authors:  Philip Kam-Tao Li; Cheuk Chun Szeto; Beth Piraino; Javier de Arteaga; Stanley Fan; Ana E Figueiredo; Douglas N Fish; Eric Goffin; Yong-Lim Kim; William Salzer; Dirk G Struijk; Isaac Teitelbaum; David W Johnson
Journal:  Perit Dial Int       Date:  2016-06-09       Impact factor: 1.756
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.